-
Societal and Economic Impact of Targeted Therapy for Breast Cancer in Bulgaria
Sep 9, 2025, 16:22 PM -
Prognostic Factor Evaluation for Clinical Outcomes in HER2-Mutant NSCLC
Sep 9, 2025, 16:22 PM -
Public Spending on Medicines Between 2018 and 2026: Lessons for Designing a New Financing Model in Portugal
Sep 9, 2025, 16:22 PM -
Quantifying the Value of Information in Early Stage Health Technology Assessment: Guiding Investment in Evidence Generation
Sep 9, 2025, 16:22 PM -
Epidemiological Insights in Merkel Cell Carcinoma Across Europe: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Incorporating Equity-of-Access Into Health Economic Evaluations: Surgical Task-Shifting for C-Sections in Sierra Leone
Sep 9, 2025, 16:22 PM -
Adapting HTA Frameworks for Precision Medicine: Methodological Advances in the UK and EU4
Sep 9, 2025, 16:22 PM -
Does Proposed IRP Introduction in the US Align With Current IRP Trends and With Best Practice Guidelines?
Sep 9, 2025, 16:22 PM -
Treatment Failure Event Categories Reveal Progressive Increases in Disease and Economic Burden Among Patients With Major Depressive Disorder
Sep 9, 2025, 16:22 PM -
Real-World Evidence Study on Healthcare Resource Utilization (HCRU) Among Cancer Patients in the Helsinki and Uusimaa (HUS) Region, Finland
Sep 9, 2025, 16:22 PM -
Social Determinants of Health Affecting Response to Opioid Addiction Treatment
Sep 9, 2025, 16:22 PM -
The Health Impact of Pembrolizumab in Combination With Chemotherapy for the First-Line Treatment of Patients With Squamous Metastatic Non-Small Cell Lung Cancer (mNSCLC) in Türkiye
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of the BCIS Conveyance Algorithm for Out-of-Hospital Cardiac Arrest Patients
Sep 9, 2025, 16:22 PM -
Use of Big Data to Assess Dyslipidemia Management in Greece: Real-World Insights From the National Healthcare Payer
Sep 9, 2025, 16:22 PM -
COVID-19's Effects on Mental Health Services: The Effectiveness of Telepsychiatry and Challenges in Substance Use Disorders in the United States
Sep 9, 2025, 16:22 PM -
Development of Two Versions of a Patient-Preference Questionnaire for Evaluating Potential HIV Cure-Related and Other HIV Interventions
Sep 9, 2025, 16:22 PM -
Baseline Risk Heterogeneity in Cost-Effectiveness Analysis of the Diabetes Prevention Program
Sep 9, 2025, 16:22 PM -
Mapping Anatomic Pathology Laboratories of Public Hospitals in Greece: Units, Infrastructure, Personnel, and Workload Estimation
Sep 9, 2025, 16:22 PM -
Spinal Muscular Atrophy Treatments in France: What Are the Organizational Economic and Environmental Impacts of Oral and Intrathecal Administrations
Sep 9, 2025, 16:22 PM -
Zero-Shot RCT Identification Using Large Language Models: A Comparative Study With the Cochrane Classifier
Sep 9, 2025, 16:22 PM
